Generic Drug Pricing Policies in India: DPCO 2013 and What It Means for Export Buyers
What this page covers
- Overview of the Drug Price Control Order (DPCO) 2013 and its role in Indian pharmaceutical pricing.
- Explanation of the National Pharmaceutical Pricing Authority (NPPA) and its functions.
- How DPCO 2013 affects prices paid by international buyers for Indian medicines.
- Guidance for export buyers to interpret Indian pharmaceutical pricing with clarity.
Generic Drug Pricing Policies in India: DPCO 2013 and What It Means for Export Buyers
India's pharmaceutical pricing policy, particularly the Drug Price Control Order (DPCO) 2013 and the National Pharmaceutical Pricing Authority (NPPA), has a direct effect on the prices international buyers pay for Indian medicines. Understanding these regulations helps buyers interpret pricing with greater clarity.
- The Drug Price Control Order (DPCO) 2013 is issued by the Government of India to regulate drug prices.
- The National Pharmaceutical Pricing Authority (NPPA) is the regulatory body responsible for implementing DPCO provisions.
- DPCO 2013 can have a counterintuitive effect on export prices, making understanding of the policy essential for international buyers.
Article Content
The article provides a detailed explanation of India's Drug Price Control Order (DPCO) 2013 and its implications for export buyers. It covers the role of the National Pharmaceutical Pricing Authority (NPPA) and how pricing policies affect the cost of Indian generic drugs for international markets.
- DPCO 2013 sets ceiling prices for essential medicines in India, influencing domestic and export pricing.
- Export buyers must understand these regulations to accurately interpret price fluctuations and cost structures.
- The NPPA monitors compliance and can revise prices, affecting long-term procurement strategies.
- Knowledge of DPCO 2013 helps buyers negotiate better terms and predict market trends.
Facts Index
| Entity | Attribute | Value | Confidence |
|---|---|---|---|
| Generic Drug Pricing Policies in India: DPCO 2013 and What It Means for Export Buyers | author | Shopify API | high |
| Generic Drug Pricing Policies in India: DPCO 2013 and What It Means for Export Buyers | publish_date | 2026-08-23T00:22:19Z | high |
Who Is This For
- International buyers and procurement professionals sourcing generic drugs from India who need to understand pricing regulations.
- Export managers and pharmaceutical distributors seeking to interpret price fluctuations due to DPCO 2013.
- Business analysts and market researchers studying Indian pharmaceutical export dynamics.
Frequently Asked Questions
What is DPCO 2013?DPCO 2013, or the Drug Price Control Order 2013, is a regulation issued by the Indian government to control the prices of essential medicines in India, indirectly affecting export pricing for international buyers.
What is the NPPA?The National Pharmaceutical Pricing Authority (NPPA) is the regulatory body that implements and monitors the DPCO provisions, including setting ceiling prices and ensuring compliance.
How does DPCO 2013 affect export prices of Indian generic drugs?DPCO 2013 sets ceiling prices for domestic sales, which can influence the cost structure and pricing strategies for exports, sometimes leading to counterintuitive effects on international prices.
When was this article published?This article was published on 2026-08-23.
Who wrote this article?The author of this article is listed as Shopify API.